Supply Of The Drug Nonakog Alpha, Hypophylysis For The Preparation Of A Solution For Ingestion, 500 Me Within The Framework Of The Implementation Of Government Decision No. 1416 Of 26.11.2018 Of The Russian Federation On The Procedure For The Provision Of Drugs To Persons Suffering From Hemophilia, Mucocicidosis, Hypophysary Nanism, Goshe Disease, Malignant Neoplasms Of Lymphoid, Blood And Related Tissues, Dispersed Sclerosis, Hemolytic Uremic Syndrome, Juvenile Arthritis With Systemic Origin, Type I, Ii And Vi Mucopolisacharidosis, Anemiamic Anemia, An Unspecified, Inherited Deficiency Of Factors Ii (Fibrinogen), Vii (Labyl), X (Stewarta-Provera), Persons After Organ Transplantation And (Or) Tissue, As Well As The Recognition Of Certain Acts Of The Government Of The Russian Federation As Null And Void"

oЕДЕРАЛЬНОЕ КАЗЕННОЕ УЧРЕЖДЕНИЕ oЕДЕРАЛЬНЫЙ ЦЕНТР ПЛАНИРОВАНИЯ И ОРГАНИЗАЦИИ ЛЕКАРСТВЕННОГО ОБЕСПЕЧЕНИЯ ГРАЖДАН МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ oЕДЕРАЦИИ Russia has Released a tender for Supply Of The Drug Nonakog Alpha, Hypophylysis For The Preparation Of A Solution For Ingestion, 500 Me Within The Framework Of The Implementation Of Government Decision No. 1416 Of 26.11.2018 Of The Russian Federation On The Procedure For The Provision Of Drugs To Persons Suffering From Hemophilia, Mucocicidosis, Hypophysary Nanism, Goshe Disease, Malignant Neoplasms Of Lymphoid, Blood And Related Tissues, Dispersed Sclerosis, Hemolytic Uremic Syndrome, Juvenile Arthritis With Systemic Origin, Type I, Ii And Vi Mucopolisacharidosis, Anemiamic Anemia, An Unspecified, Inherited Deficiency Of Factors Ii (Fibrinogen), Vii (Labyl), X (Stewarta-Provera), Persons After Organ Transplantation And (Or) Tissue, As Well As The Recognition Of Certain Acts Of The Government Of The Russian Federation As Null And Void" in Healthcare and Medicine. The tender was released on Apr 18, 2024.

Country - Russia

Summary - Supply Of The Drug Nonakog Alpha, Hypophylysis For The Preparation Of A Solution For Ingestion, 500 Me Within The Framework Of The Implementation Of Government Decision No. 1416 Of 26.11.2018 Of The Russian Federation On The Procedure For The Provision Of Drugs To Persons Suffering From Hemophilia, Mucocicidosis, Hypophysary Nanism, Goshe Disease, Malignant Neoplasms Of Lymphoid, Blood And Related Tissues, Dispersed Sclerosis, Hemolytic Uremic Syndrome, Juvenile Arthritis With Systemic Origin, Type I, Ii And Vi Mucopolisacharidosis, Anemiamic Anemia, An Unspecified, Inherited Deficiency Of Factors Ii (Fibrinogen), Vii (Labyl), X (Stewarta-Provera), Persons After Organ Transplantation And (Or) Tissue, As Well As The Recognition Of Certain Acts Of The Government Of The Russian Federation As Null And Void"

Deadline - login to view

GT reference number - 81059862

Product classification - Medical equipments, pharmaceuticals and personal care products